AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ENDRA Life Sciences Inc. Director's Dealing 2020

Apr 15, 2020

35444_dirs_2020-04-15_80f59e79-2062-4f83-940d-f93d08fed75d.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2020-04-09

Reporting Person: Basenese Lou (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	7481	Direct